Adipocytokines: A bridge connecting obesity and insulin resistance

被引:25
作者
Zhuang, Xiao-Feng [1 ]
Zhao, Ming-Ming [2 ]
Weng, Cui-Lian [1 ]
Sun, Ning-Ling [1 ]
机构
[1] Peking Univ, Peoples Hosp, Dept Cardiol, Beijing 100044, Peoples R China
[2] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing 100044, Peoples R China
关键词
VISCERAL ADIPOSE-TISSUE; MESSENGER-RNA EXPRESSION; TNF-ALPHA; SUBCUTANEOUS FAT; PPAR-GAMMA; ADIPONECTIN; PROTEIN; LEPTIN; ACCUMULATION; SENSITIVITY;
D O I
10.1016/j.mehy.2009.05.036
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Overweight or obesity has become a critical health problem in the world. The association of obesity with type 2 diabetes mellitus (T2D) has been recognized for decades, and the major basis for this link is the ability of obesity to engender insulin resistance (IR). Adipose tissue is not only an energy depot but also an active endocrine organ. Furthermore, fat distribution in the body is important for the progress of IR. Many studies show that visceral fat is more important in relation to IR than subcutaneous fat. Circulating free fatty acids (FFAs) derived from adipocytes are elevated in many IR states and have been suggested to be a main underlying mechanism of IR in obesity-associated T2D. However, compelling evidence demonstrates that adipocytokines including several adipocyte-derived cytokines or hormones are also involved in obesity-induced IR. Therefore, we hypothesise that adipocytokines may be a bridge connecting obesity and IR, and abnormal fat depot distribution or visceral fat/subcutaneous fat ratio (VIS ratio) in obesity also could be a primer for IR. When visceral fat accumulates and V/S ratio deteriorates, just like a primer,in visceral obesity it should begin to display unhealthy effect begin to take place in the body. In addition to it, as one of physiological regulation mechanisms of the body, most of the adipocytokines from the visceral fat reduce the visceral fat volume or normalize the V/S ratio. Actually, on the contrary, with serum a change in the serum adipocytokine level and an imbalance of them in the body for a long term, it will become a pathological condition and various kinds of effects may contribute to the development of IR. If confirmed, this hypothesis may lead to the formulation of new pathogenesis and new therapeutic approaches to IR. For example, an effective slimming pill will be assessed in future on the basis of the decrease of V/S and serum adipocytokines level rather than of body weight. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:981 / 985
页数:5
相关论文
共 41 条
[31]   Regional differences in the response of human pre-adipocytes to PPARγ and RXRα agonists [J].
Sewter, CP ;
Blows, F ;
Vidal-Puig, A ;
O'Rahilly, S .
DIABETES, 2002, 51 (03) :718-723
[32]   Enhanced expression of PAI-1 in visceral fat: Possible contributor to vascular disease in obesity [J].
Shimomura, I ;
Funahashi, T ;
Takahashi, M ;
Maeda, K ;
Kotani, K ;
Nakamura, T ;
Yamashita, S ;
Miura, M ;
Fukuda, Y ;
Takemura, K ;
Tokunaga, K ;
Matsuzawa, Y .
NATURE MEDICINE, 1996, 2 (07) :800-803
[33]  
SM O, 2003, NUTR NEUROSCI, V6, P163
[34]   Insulin signaling and action in fat cells: Associations with insulin resistance and type 2 diabetes [J].
Smith, U ;
Axelsen, M ;
Carvalho, E ;
Eliasson, B ;
Jansson, PA ;
Wesslau, C .
THE METABOLIC SYNDROME X: CONVERGENCE OF INSULIN RESISTANCE, GLUCOSE INTOLERANCE, HYPERTENSION, OBESITY, AND DYSLIPIDEMIAS-SEARCHING FOR THE UNDERLYING DEFECTS, 1999, 892 :119-126
[35]  
SULEYMANOGLU S, 2009, DIABETES RES CLIN PR
[36]   Adipose tissue-derived factors: Impact on health and disease [J].
Trujillo, Maria E. ;
Scherer, Philipp E. .
ENDOCRINE REVIEWS, 2006, 27 (07) :798-+
[37]   Differential effects of leptin in regulation of tissue glucose utilization in vivo [J].
Wang, JL ;
Chinookoswong, N ;
Scully, S ;
Qi, MY ;
Shi, ZQ .
ENDOCRINOLOGY, 1999, 140 (05) :2117-2124
[38]   Regulation of apelin mRNA expression by insulin and glucocorticoids in mouse 3T3-L1 adipocytes [J].
Wei, L ;
Hou, XH ;
Tatemoto, K .
REGULATORY PEPTIDES, 2005, 132 (1-3) :27-32
[39]   MECHANISM FOR STIMULATION IN VIVO OF HEPATIC GLUCONEOGENESIS BY GLUCAGON [J].
WILLIAMSON, JR .
BIOCHEMICAL JOURNAL, 1966, 101 (01) :C11-+
[40]   Expression of tumor necrosis factor (TNF)-α protein in the subcutaneous and visceral adipose tissue in correlation with adipocyte cell volume, serum TNF-α, soluble serum TNF-receptor-2 concentrations and C-peptide level [J].
Winkler, G ;
Kiss, S ;
Keszthelyi, L ;
Sápi, Z ;
Öry, I ;
Salamon, F ;
Kovács, M ;
Vargha, P ;
Szekeres, O ;
Speer, G ;
Karádi, I ;
Sikter, M ;
Kaszás, E ;
Dworak, O ;
Gerö, G ;
Cseh, K .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2003, 149 (02) :129-135